Discover how cancer cells survive in low-glucose environments and evade chemotherapy-induced death. New study sheds light on ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

Millions of people around the world are diagnosed with cancer each year. The rapid proliferation of mutated cells can fatally ...

11月5日，南昌大学傅斌教授研究团队在期刊《Cell Death&Disease》上发表了研究论文，题为“USP3 promotes DNA damage response and chemotherapy resistance through ...

Chemotherapy targets cancer cells by disrupting DNA replication and mitotic processes, despite side effects on healthy cells.

A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...

A groundbreaking study by researchers from RMIT University in Australia and Indian institutions has unveiled a novel ...

Joshua K. Sabari, MD, discusses the antitumor activity of second-line lurbinectedin, noting an ORR of 45%, a median DOR of ...

In the fight against antibiotic-resistant pneumonia, new research published in the Antimicrobial Agents and Chemotherapy ...

The European Commission has approved mirvetuximab soravtansine for select patients with pretreated folate receptor–alpha (FRα)-positive, platinum-resistant ovarian cancer.